Abstract

CLC Number:

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/

https://zgywjj.magtechjournal.com/EN/Y2016/V13/I4/251

[1] Li X, Chen J, Zhang L , et al. Clinical observation of the adverse drug reactions caused by non-ionic iodinated contrast media: results from 109,255 cases who underwent enhanced CT examination in Chongqing,China[J]. Br J Radiol, 2015, 88(1047):20140491.
[2] Palkowitsch P, Lengsfeld P, Stauch K, et al.Safety and diagnostic image quality of iopromide: results of a large non-interventional observational study of European and Asian patients (IMAGE)[J].Acta Radiol, 2012,53(2):179-186.
[3] Palkowitsch P K, Bostelmann S, Lengsfeld P. Safety and tolerability of iopromide intravascular use: a pooled analysis of three non-interventional studies in 132,012 patients[J]. Acta Radiol, 2014, 55(6):707-714.
[4] Zhang B C, Hou L, Lv B, et al. Post-marketing surveillance study with iodixanolin 20 185 Chinese patients from routine clinical practices[J]. Br J Radiol, 2014,87(1034):20130325.
[5] Bavbek S, Szener Z C, Aydin O, et al. First case report of acute generalized exanthematous pustulosis due to intravenous iopromide [J]. J Investig Allergol Clin Immunol, 2014,24(1):66-67.
[6] 张运剑,王晓芳,胡萍,等.碘普罗胺致非心源性肺水肿[J].药物不良反应杂志,2013,15(2):98-100.
[7] Yang Y, Yang D, Yang D, et al. Role of reactive oxygen species-mediated endoplasmic reticulum stress in contrast-induced renal tubular cell apoptosis[J]. Nephron Exp Nephrol, 2014,128(1-2):30-36.
[8] CFDA.药品不良反应信息通报（第52期）:警惕碘普罗胺注射液和红花注射液的严重不良反应[EB/OL].(2013-02-06)[2015-11-10].http://www.cfda.gov.cn/WS01/CL0078/78111.html.
[9] 郝素珍,王桂琴.医学免疫学[M].北京:人民卫生出版社,2010:198.
[10] 葛均波,徐永健.内科学[M].8版,北京:人民卫生出版社,2014:363-364
[11] 颜光美.药理学[M].北京:高等教育出版社,2009:178.
[12] 侯玉华,杨彬,姬海清.急性脑梗死与上消化道出血的研究[J].中风与神经疾病杂志,2001,18(1):56-56.
[13] 国家药典委员会.中华人民共和国临床用药须知[M].北京:人民卫生出版社,2005:892.
[14] Trcka J, Schmidt C, Seitz C S, et al.Anaphylaxis to iodinated contrast material: nonallergic hypersensitivity or IgE-mediated allergy? [J].AJR Am J Roentgenol, 2008,190(3):666-670.
[15] 裴泽军.碘普罗胺注射液说明书中过敏试验的建议[J].中国医院药学杂志,2012,32(12):982.
[16] Ahn Y H, Koh Y I, Kim J H, et al. The potential utility of iodinated contrast media (ICM) skin testing in patients with ICM hypersensitivity[J]. J Korean Med Sci, 2015, 30(3):245-251.
[17] Kim M H, Lee S Y, Lee S E, et al.Anaphylaxis to iodinated contrast media: clinical characteristics related with development of anaphylactic shock[J]. PLoS One, 2014, 9(6):e100154.
[18] Thomsen H S. European Society of Urogenital Radiology (ESUR) guidelines on the safe use of iodinated contrast media[J]. Eur J Radiol, 2006,60(3):307-313.
[19] Baig M, Farag A, Sajid J, et al. Shellfish allergy and relation to iodinatedcontrast media: United Kingdom survey[J]. World J Cardiol, 2014, 6(3):107-111.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

[1]	LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850.
[2]	WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855.
[3]	XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862.
[4]	CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875.
[5]	CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882.
[6]	ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888.
[7]	SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895.
[8]	SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919.
[9]	YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923.
[10]	KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927.
[11]	LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932.
[12]	LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936.
[13]	ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940.
[14]	ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943.
[15]	CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946.